We confirmed the expression of a gene that is involved in immune tolerance to inflammation35 (e.g., RELB) and apoptosis-inducing tumor-suppressor genes38,48 (e.g., BCL2L11 and KLF10). The gene discussed is BCL2L11; the disease is neoplasm.